No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹22.5Prev. Close
₹23.62Turnover(Lac.)
₹0.22Day's High
₹24.8Day's Low
₹22.4552 Week's High
₹95.1452 Week's Low
₹22.45Book Value
₹22.14Face Value
₹10Mkt Cap (₹ Cr.)
14.13P/E
22.55EPS
1.1Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 4.66 | 4.66 | 4.66 | 4.66 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 5.29 | 4.82 | 4.47 | 4.62 |
Net Worth | 9.95 | 9.48 | 9.13 | 9.28 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 6.59 | 5.08 | 5.09 | 5.08 |
yoy growth (%) | 29.71 | -0.08 | 0.15 | 1.41 |
Raw materials | -3.49 | -2.33 | -2.5 | -2.42 |
As % of sales | 52.96 | 45.99 | 49.22 | 47.63 |
Employee costs | -1.01 | -0.87 | -0.71 | -0.79 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.54 | 0.37 | 0.34 | 0.34 |
Depreciation | -0.26 | -0.26 | -0.23 | -0.21 |
Tax paid | -0.12 | -0.07 | -0.06 | -0.05 |
Working capital | 0.21 | 0.13 | 0.39 | -0.4 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 29.71 | -0.08 | 0.15 | 1.41 |
Op profit growth | 21 | 12.82 | 4.95 | -9 |
EBIT growth | 32.3 | 13.48 | 2.71 | -7.68 |
Net profit growth | 37.87 | 7.6 | 0.6 | -3.37 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,850.4 | 101.73 | 4,43,972.94 | 705.44 | 0.86 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,706.1 | 69.2 | 1,78,025.88 | 598 | 0.45 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,357.5 | 66.03 | 1,47,477.6 | 577 | 0.14 | 2,547 | 249.82 |
Lupin Ltd LUPIN | 2,442.35 | 20.19 | 1,11,668.12 | 717.45 | 0.49 | 4,433.96 | 595.44 |
Cipla Ltd CIPLA | 1,365.25 | 24.07 | 1,10,282.52 | 616.88 | 1.17 | 4,256.93 | 411.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Tosh Kumar Jain
Whole-time Director
Arihant Kumar Jain
Whole-time Director
Monika Jain
Independent Director
Rajesh Kumar Gupta
Independent Director
MrCheena Golani
Company Sec. & Compli. Officer
Sohini Bansal
Independent Director
Shruti Gupta
Bhagwant Kuti,
Kankhal,
Uttarakhand - 249408
Tel: 91-1334-243833
Website: http://www.deshrakshak.com
Email: deshrakshak@yahoo.com; dral95@yahoo.com; daral96@y
T-34 2nd Floor,
Okhla Industrial Are, Phase II,
New Delhi - 110020
Tel: 91-011-26387281/83
Website: www.masserv.com
Email: info@massere.com
Summary
The flagship company Desh Rakshak Aushdhalaya Limited of Bhagwant Group was originally started in 1901 as a Proprietorship Concern by Late Shri Bhagwant Rai Jain, a well renowned Vaidya Father of Late...
Read More
Reports by Desh Rakshak Aushdhalaya Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Reg. No. INM000010940, SEBI RA Regn. No: INH000000248, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.